불안장애 및 우울증 치료 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 적응증별, 지역별, 경쟁별(2020-2030년)
Anxiety Disorders and Depression Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Indication, By Region, By Competition, 2020-2030F
상품코드:1881658
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 불안장애 및 우울증 치료 시장은 2024년에 112억 7,000만 달러로 평가되었으며, 2030년까지 CAGR 5.93%로 성장하여 159억 2,000만 달러에 달할 것으로 예측됩니다.
세계 불안장애 및 우울증 치료 시장은 항우울제, 항불안제, 기분안정제 등의 약리학적 개입과 더불어 이러한 광범위한 정신질환을 앓고 있는 환자들의 증상 완화 및 치료 성과 향상을 위한 다양한 심리치료 및 신경자극 기술을 포함하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
112억 7,000만 달러
시장 규모 : 2030년
159억 2,000만 달러
CAGR : 2025-2030년
5.93%
가장 빠르게 성장하는 부문
항우울제
최대 시장
북미
주요 시장 촉진요인
세계 불안장애 및 우울증 치료 시장은 전 세계 정신질환 발생률의 증가와 치료 전략의 지속적인 혁신에 의해 크게 영향을 받고 있습니다. 전 세계적으로 불안장애와 우울증의 유병률 증가는 치료를 필요로 하는 대상 환자층을 직접적으로 확대하여 시장 성장을 촉진하는 기본 요인이 되고 있습니다.
주요 시장 과제
새로운 치료 솔루션 개발 및 제공에 따른 막대한 경제적 부담은 전 세계 불안장애 및 우울증 치료제 시장의 성장을 직접적으로 저해하고 있습니다. 새로운 항우울제, 항불안제 및 첨단 신경자극 기술 개발에는 방대한 연구개발 단계가 필요하며, 막대한 자금 투자가 요구됩니다.
주요 시장 동향
디지털 치료법 및 원격의료 솔루션의 확대는 치료의 접근성과 확장성을 높여 불안장애 및 우울증 치료 시장에 큰 영향을 미치고 있습니다. 이러한 플랫폼은 기술을 활용하여 근거에 기반한 중재를 원격으로 제공함으로써, 특히 의료 서비스가 부족한 지역에서 보다 광범위한 환자층에 도달할 수 있습니다.
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 불안장애 및 우울증 치료 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
제품별(항우울제, 치료·의료기기, 기타)
적응증별(강박장애, 주요우울장애, 공포증, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 불안장애 및 우울증 치료 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 불안장애 및 우울증 치료 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 불안장애 및 우울증 치료 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 불안장애 및 우울증 치료 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 불안장애 및 우울증 치료 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 불안장애 및 우울증 치료 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Abbvie Inc.
Bristol-Myers Squibb Company
Eli Lily & Co
GlaxoSmithKline Plc
H. Lundbeck A/S
Johnson & Johnson Services, Inc.
Merck & Co. Inc
Pfizer Inc
Sanofi
Axsome Therapeutics Inc
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Anxiety Disorders and Depression Treatment Market, valued at USD 11.27 Billion in 2024, is projected to experience a CAGR of 5.93% to reach USD 15.92 Billion by 2030. The Global Anxiety Disorders and Depression Treatment Market encompasses a range of pharmacological interventions, including antidepressants, anxiolytics, and mood stabilizers, alongside various psychotherapeutic modalities and neurostimulation techniques designed to alleviate symptoms and improve outcomes for individuals suffering from these pervasive mental health conditions.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 11.27 Billion
Market Size 2030
USD 15.92 Billion
CAGR 2025-2030
5.93%
Fastest Growing Segment
Antidepressant Drugs
Largest Market
North America
Key Market Drivers
The Global Anxiety Disorders and Depression Treatment Market is significantly influenced by the escalating worldwide incidence of mental health conditions and ongoing innovations in therapeutic strategies. The rising global prevalence of anxiety and depression disorders directly expands the addressable patient population requiring interventions, thereby acting as a fundamental growth catalyst for the market. This demographic shift necessitates broader access to diagnostic tools and diverse treatment options.
Key Market Challenges
The substantial economic burden linked to developing and delivering novel therapeutic solutions directly impedes the growth of the Global Anxiety Disorders and Depression Treatment Market. The extensive research and development phases for new antidepressants, anxiolytics, and advanced neurostimulation techniques necessitate considerable financial investment. These high costs ultimately translate into elevated pricing for new treatments, making them less accessible, particularly in regions with limited healthcare budgets and less developed infrastructure.
Key Market Trends
The expansion of digital therapeutics and telehealth solutions significantly influences the anxiety disorders and depression treatment market by enhancing accessibility and scalability of care. These platforms leverage technology to deliver evidence-based interventions remotely, reaching a broader patient population, particularly in underserved areas. According to GSMA's Mobile Economy 2024 report, approximately 5.6 billion people worldwide were mobile service subscribers in 2023, providing a vast infrastructure for these digital health services.
Key Market Players
Abbvie Inc.
Bristol-Myers Squibb Company
Eli Lily & Co
GlaxoSmithKline Plc
H. Lundbeck A/S
Johnson & Johnson Services, Inc.
Merck & Co. Inc
Pfizer Inc
Sanofi
Axsome Therapeutics Inc
Report Scope:
In this report, the Global Anxiety Disorders and Depression Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Anxiety Disorders and Depression Treatment Market, By Product:
Antidepressant Drugs
Therapy and Devices
Others
Anxiety Disorders and Depression Treatment Market, By Indication:
Obsessive-Compulsive Disorder
Major Depressive Disorder
Phobia
Others
Anxiety Disorders and Depression Treatment Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Anxiety Disorders and Depression Treatment Market.
Available Customizations:
Global Anxiety Disorders and Depression Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Anxiety Disorders and Depression Treatment Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Antidepressant Drugs, Therapy and Devices, Others)
5.2.2. By Indication (Obsessive-Compulsive Disorder, Major Depressive Disorder, Phobia, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Anxiety Disorders and Depression Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Indication
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Anxiety Disorders and Depression Treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Indication
6.3.2. Canada Anxiety Disorders and Depression Treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Indication
6.3.3. Mexico Anxiety Disorders and Depression Treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Indication
7. Europe Anxiety Disorders and Depression Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Indication
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Anxiety Disorders and Depression Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Indication
7.3.2. France Anxiety Disorders and Depression Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Indication
7.3.3. United Kingdom Anxiety Disorders and Depression Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Indication
7.3.4. Italy Anxiety Disorders and Depression Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Indication
7.3.5. Spain Anxiety Disorders and Depression Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Indication
8. Asia Pacific Anxiety Disorders and Depression Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Indication
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Anxiety Disorders and Depression Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Indication
8.3.2. India Anxiety Disorders and Depression Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Indication
8.3.3. Japan Anxiety Disorders and Depression Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Indication
8.3.4. South Korea Anxiety Disorders and Depression Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Indication
8.3.5. Australia Anxiety Disorders and Depression Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Indication
9. Middle East & Africa Anxiety Disorders and Depression Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Indication
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Anxiety Disorders and Depression Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Indication
9.3.2. UAE Anxiety Disorders and Depression Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Indication
9.3.3. South Africa Anxiety Disorders and Depression Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Indication
10. South America Anxiety Disorders and Depression Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Indication
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Anxiety Disorders and Depression Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Indication
10.3.2. Colombia Anxiety Disorders and Depression Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Indication
10.3.3. Argentina Anxiety Disorders and Depression Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Indication
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Anxiety Disorders and Depression Treatment Market: SWOT Analysis
